Skip to content
Riskpilot
← Back to search
Sign in
Get full access
Guard Therapeutics International AB (publ)
AB
Active
Org 5567553226
Scheelevägen 22, 223 63
Lund
Research and experimental development on natural sciences and engineering
· NACE 7210
Est. 2008
5-9 employees
Watchlist
Share
Sweden
/
Companies
/
Research and experimental development on natural sciences and engineering
/
Guard Therapeutics International AB (publ)
Overview
Financials
People & ownership
Related companies
Loading company…
Financials
Revenue
SEK millions
0M
0M
1M
1M
1M
0M
2020
0M
2021
0M
2022
0M
2023
0M
2024
EBITDA
SEK millions
0M
-12M
-23M
-35M
-46M
-40M
2020
-82M
2021
-115M
2022
-115M
2023
-100M
2024
Income statement
SEK thousands
Item
2020
2021
2022
2023
2024
Revenue
0
0
0
0
0
Staff expenses
—
—
—
—
—
EBITDA
−40 277
−81 900
−114 921
−115 073
−99 905
Depreciation & amort.
—
—
—
—
—
EBIT
−40 277
−81 900
−114 921
−115 073
−99 905
Net financials
−14
−279
2 081
1 306
3 832
Profit before tax
−40 284
−82 030
−112 839
−113 323
−96 066
Tax
−0
−0
−0
−0
−0
Net profit
−40 284
−82 030
−112 839
−113 323
−96 066
Balance sheet
SEK thousands
Item
2020
2021
2022
2023
2024
Total assets
91 222
190 437
202 605
85 227
55 741
Equity
79 686
175 776
177 360
66 733
37 967
Long-term debt
5 032
3 719
2 550
1 413
0
Short-term debt
6 503
10 942
22 696
16 613
17 735
Total debt
11 535
14 661
25 246
18 026
17 735
Financial ratios
5-year trend
EBITDA margin
-9990500000.0%
This company
15.8%
Market median
-63231012758% vs market
2020
2024
Equity ratio
68.1%
This company
38.2%
Market median
+78% vs market
2020
2024
Return on equity
-253.0%
This company
18.4%
Market median
-1475% vs market
2020
2024
Net profit margin
-9606600000.0%
This company
8.1%
Market median
-118600000100% vs market
2020
2024
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
2020
2024
Debt / equity
0.47×
This company
0.62×
Market median
+24% vs market
2020
2024
Annual reports & filings
Annual report 2024
Filed via Bolagsverket / SCB · Period 2024-01-01 – 2024-12-31
View
PDF
Annual report 2023
Filed via Bolagsverket / SCB · Period 2023-01-01 – 2023-12-31
View
PDF
Annual report 2022
Filed via Bolagsverket / SCB · Period 2022-01-01 – 2022-12-31
View
PDF
Annual report 2021
Filed via Bolagsverket / SCB · Period 2021-01-01 – 2021-12-31
View
PDF
Annual report 2020
Filed via Bolagsverket / SCB · Period 2020-01-01 – 2020-12-31
View
PDF
More on Guard Therapeutics International AB (publ)
Overview →
Headline figures, risk assessment and company summary
People & ownership →
Management, board and shareholder breakdown
Related companies →
Corporate hierarchy, parent and subsidiary network
